Search Results - "Bitler, Benjamin"

Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancer.

Authors: Bitler, Benjamin G. Lang, Julie Nunez-Avellaneda, Daniel et al.

Source: Scientific Reports. 11/10/2025, Vol. 15 Issue 1, p1-22. 22p.

Bayesian multi-cell type models for the analysis of complex immune cell populations with application to ovarian cancer.

Authors: Sakitis, Chase J Laborde, Jose Wrobel, Julia et al.

Source: Briefings in Bioinformatics; Jan2026, Vol. 27 Issue 1, p1-16, 16p

SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data.

Authors: Seal, Souvik Bitler, Benjamin G. Ghosh, Debashis

Source: PLoS Genetics. 10/20/2023, Vol. 19 Issue 10, p1-25. 25p.

This result is not displayed to guests.
Login for full access.

Combining p38 Inhibition with chemotherapy promotes T-cell infiltration and limits growth of therapy resistant high grade serous carcinoma tumors.

Authors: Bitler, Benjamin Woodruff, Elizabeth Kostka-Newman, Zander et al.

Source: Gynecologic Oncology. May2026:Supplement, Vol. 208, pS395-S395. 1p.

This result is not displayed to guests.
Login for full access.

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.

Authors: Bitler, Benjamin G Aird, Katherine M Garipov, Azat et al.

Source: Nature Medicine. Mar2015, Vol. 21 Issue 3, p231-238. 8p. 6 Graphs.

Models of high-grade serous carcinoma of tubo-ovarian origin.

Authors: Padmanabhan, Achuth Dwivedi, Shailendra Merritt, Melissa A. et al.

Source: Oncology Reviews. 2026, p1-23. 23p.

Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum.

Authors: Culp-Hill, Rachel Nichols, Charles M. Kilkenny, Shannon et al.

Source: Diagnostics (2075-4418). Jul2026, Vol. 16 Issue 14, p2143. 22p.

This result is not displayed to guests.
Login for full access.

Ovarian cancer think tank: the use of integrated artificial intelligence and computational biology in ovarian cancer diagnosis and treatment.

Authors: Ehimiaghe, Eseohi Dimmick, Hannah Spinosa, Daniel et al.

Source: European Journal of Gynaecological Oncology. Jan2026, Vol. 47 Issue 1, p15-20. 6p.

PARP inhibitors: Clinical utility and possibilities of overcoming resistance.

Authors: Bitler, Benjamin G. Watson, Zachary L. Wheeler, Lindsay J. et al.

Source: Gynecologic Oncology. Dec2017, Vol. 147 Issue 3, p695-704. 10p.

This result is not displayed to guests.
Login for full access.

SPF: A spatial and functional data analytic approach to cell imaging data.

Authors: Vu, Thao Wrobel, Julia Bitler, Benjamin G. et al.

Source: PLoS Computational Biology. 6/15/2022, Vol. 18 Issue 6, p1-21. 21p. 1 Chart, 7 Graphs.

Clinical Evaluation of a Multi-Omic Diagnostic Model for Early-Stage Ovarian Cancer Detection.

Authors: Law, Robert A. Giles, Brendan M. Culp-Hill, Rachel et al.

Source: Diagnostics (2075-4418). Sep2025, Vol. 15 Issue 17, p2225. 16p.

Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence.

Authors: Bitler, Benjamin G. Nicodemus, Jasmine P. Hua Li et al.

Source: Cancer Research. Oct2011, Vol. 71 Issue 19, p6184-6194. 11p.

This result is not displayed to guests.
Login for full access.

P28 Defining the role of Cannabidiol's effect in ovarian cancer.

Authors: Greenwood, Ashley Bitler, Benjamin

Source: Gynecologic Oncology. 2023 Supplement 1, Vol. 173, pS25-S25. 1p.

RF5 Folate receptor alpha protein expression in ovarian serous cystadenocarcinoma tumors of The Cancer Genome Atlas: Exploration beyond single-agent therapy.

Authors: Persenaire, Christianne Bitler, Benjamin Corr, Bradley

Source: Gynecologic Oncology. 2023 Supplement 1, Vol. 173, pS7-S7. 1p.

Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations.

Authors: Bitler, Benjamin G Aird, Katherine M Zhang, Rugang

Source: Molecular & Cellular Oncology. 2016, Vol. 3 Issue 1, p1-1. 1p.